|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization expense | |||||
| Impairment of long-lived assets | |||||
| Non-cash lease expense, net of tenant improvement allowance | |||||
| Stock-based compensation expense | |||||
| Gain on deconsolidation of Revelar | |||||
| Change in fair value of contingent considerations and holdbacks | |||||
| Gain on sale of business | |||||
| Other non-cash adjustments | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued compensation | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Business acquisition, net of cash acquired | |||||
| Deconsolidation of cash and cash equivalent relating to Revelar | |||||
| Purchases of investments | |||||
| Proceeds from maturity of investments | |||||
| Proceeds from sale of business | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from public offerings, net of underwriting discounts, commissions and offering expenses | |||||
| Proceeds from the issuance of liability related to sale of future revenue | |||||
| Proceeds from issuance under employee stock purchase plan | |||||
| Repayments of long-term debt | |||||
| Repurchases of common stock for income tax withholding | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Non-cash investing and financing activities | |||||
| Property and equipment additions included in accrued expenses and accounts payable | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Issuance of common stock in connection with the business acquisition | |||||
| Tenant improvement allowance capitalized in property and equipment | |||||
| Equity securities received as consideration for sale of business | |||||
| Promissory note receivable received as consideration for sale of business | |||||
| Conversion of convertible notes | |||||
Loading...